International Journal of Nephrology

Kidney Disease in Disadvantaged Populations


Publishing date
20 Jul 2012
Status
Published
Submission deadline
02 Mar 2012

1Department of Medicine, Puget Sound Healthcare System, University of Washington, Seattle, WA, USA

2Renal Division, Brigham and Women's Hospital, Boston, MA 02115, USA

3Renal Unit, the Queen Elizabeth Hospital, SA, Australia


Kidney Disease in Disadvantaged Populations

Description

Kidney disease may affect specific populations around the world. Populations at higher risk for kidney disease include individuals of both nonindigenous and indigenous origins. In the North America sub-continent, African Americans, Latinos, Native American Indians, Alaska Natives, Native Hawaiians of the USA, and First Nation Communities of Canada are at higher risk. In the Pacific region, Aborigines of Australia, the Maoris of New Zealand, and the Pacific Islanders also have a predilection for kidney disease.

Studies suggest that peoples from the Indian subcontinent and from Africa as well as those living in economically disadvantaged communities may also be affected. A vulnerable population may be least able to muster either public health, scientific, or clinical resources to address the problems posed by kidney failure. The disadvantage may impact on the detection, clinical course, treatment, or prognosis of kidney disease. Further, kidney disease encompasses the spectrum from acute kidney injury (AKI), glomerulonephritis, chronic kidney disease (CKD), dialysis, and transplantation. Related comorbid conditions may also be important, including the impact of hypertension, maternal factors during pregnancy, diabetes mellitus, cultural issues, and social disparities.

We invite investigators to contribute original research articles, as well as commentaries, clinical case reports, and review articles that will stimulate continuing efforts to understand the epidemiology, risk factors, underlying genetics, and/or clinical and economic aspects of how kidney disease affects disadvantaged populations, as well as the converse, the impact of a disadvantaged setting on the detection, clinical course, and treatment of kidney disease. Potential topics include, but are not limited to:

  • The prevalence of kidney disease in disadvantaged populations
  • Screening strategies for patients with kidney disease
  • The role of government and competing priorities in minority
  • Populations and developing nations
  • The potential effects of maternal factors on the development of hypertension and kidney disease in disadvantaged populations
  • CKD in the urban poor
  • Glomerulonephritis in disadvantaged populations
  • The economic and social burden of kidney transplantation in disadvantaged populations
  • The impact of disadvantage on the progression of kidney disease
  • The impact of AKI as a risk factor for CKD in disadvantaged populations
  • Global approaches for understanding the disproportionate burden of chronic kidney disease
  • Mechanisms for increased prevalence of renal disease (genetic and socioeconomic or other) in disadvantaged populations

Articles published in this special issue will not be subject to the journal's Article Processing Charges.

Before submission authors should carefully read over the journal's Author Guidelines, which are located at http://www.hindawi.com/journals/ijn/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/ according to the following timetable:


Articles

  • Special Issue
  • - Volume 2012
  • - Article ID 427589
  • - Editorial

Kidney Disease in Disadvantaged Populations

Rudolph A. Rodriguez | Li-Li Hsiao | ... | David Pugsley
  • Special Issue
  • - Volume 2012
  • - Article ID 580437
  • - Research Article

Meta-Analysis of Randomized Controlled Trials on Androgens versus Erythropoietin for Anaemia of Chronic Kidney Disease: Implications for Developing Countries

B. Adamu | S. M. Ma'aji | ... | I. M. Tleyjeh
  • Special Issue
  • - Volume 2012
  • - Article ID 240173
  • - Clinical Study

Prevalence and Correlates of Microalbuminuria in Children with Sickle Cell Anaemia: Experience in a Tertiary Health Facility in Enugu, Nigeria

Christopher Bismarck Eke | Henrietta Uche Okafor | Bede Chidozie Ibe
  • Special Issue
  • - Volume 2012
  • - Article ID 748984
  • - Clinical Study

Variation in APOL1 Contributes to Ancestry-Level Differences in HDLc-Kidney Function Association

Amy Rebecca Bentley | Ayo P. Doumatey | ... | Charles N. Rotimi
  • Special Issue
  • - Volume 2012
  • - Article ID 235234
  • - Clinical Study

Association between Urinary N-Acetyl-Beta-D-Glucosaminidase and Microalbuminuria in Diabetic Black Africans

Francis Patrick Udomah | Udeme Ekpenyong Ekrikpo | ... | Solomon Kadiri
  • Special Issue
  • - Volume 2012
  • - Article ID 730920
  • - Clinical Study

Circulating Adiponectin Is Associated with Renal Function Independent of Age and Serum Lipids in West Africans

A. P. Doumatey | J. Zhou | ... | C. N. Rotimi
  • Special Issue
  • - Volume 2012
  • - Article ID 639653
  • - Clinical Study

A Single-Center 7-Year Experience with End-Stage Renal Disease Care in Nigeriaโ€”A Surrogate for the Poor State of ESRD Care in Nigeria and Other Sub-Saharan African Countries: Advocacy for a Global Fund for ESRD Care Program in Sub-Saharan African Countries

Datonye Dennis Alasia | Pedro Emem-Chioma | Friday Samuel Wokoma
  • Special Issue
  • - Volume 2012
  • - Article ID 469265
  • - Review Article

Chronic Kidney Disease in Disadvantaged Populations

David Martins | Lawrence Agodoa | Keith Norris
International Journal of Nephrology
 Journal metrics
See full report
Acceptance rate11%
Submission to final decision100 days
Acceptance to publication16 days
CiteScore2.500
Journal Citation Indicator0.550
Impact Factor2.1
 Submit Check your manuscript for errors before submitting

We have begun to integrate the 200+ Hindawi journals into Wileyโ€™s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.